Raloxifene is known to raise the risk of blood clots. But in a 2006 US clinical trial comparing the drug with tamoxifen for breast cancer prevention, ...
Many drugs, such as alendronate (Fosamax®), and raloxifene (Evista®), work by decreasing bone resorption. They can improve bone density by two to 10 percent ...
Compared with 2008, research and development expenses grew 13 percent due primarily to the ImClone acquisition and increased late-stage clinical trial costs ...
